SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-077061
Filing Date
2007-12-21
Accepted
2007-12-21 09:47:24
Documents
1
Period of Report
2007-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd183557.html 3  
1 FORM 3 rrd183557.xml 3 3745
  Complete submission text file 0001181431-07-077061.txt   6373
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Issuer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19034 | Film No.: 071321027
SIC: 2834 Pharmaceutical Preparations

Mailing Address 174, AVENUE DE FRANCE PARIS I0 75013
Business Address 174, AVENUE DE FRANCE PARIS I0 75013 011 33 1 53 77 40 00
Sanofi-Aventis Amerique du Nord S.N.C. (Reporting) CIK: 0001421144 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19034 | Film No.: 071321026